UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 61

Sortiert nach

Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients

Therapeutic advances in medical oncology, 2018-01, Vol.10, p.1758834017749748-1758834017749748

2018

Link zum Volltext

Verfügbarkeit prüfen

Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial

Nature communications, 2021-12, Vol.12 (1), p.7008-7008, Article 7008

2021

Link zum Volltext

Verfügbarkeit prüfen

Liposomal Doxorubicin in the Treatment of Breast Cancer Patients: A Review

Journal of Drug Delivery, 2013-01, Vol.2013, p.456409-12

2013

Link zum Volltext

Verfügbarkeit prüfen

Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM)

Journal for immunotherapy of cancer, 2021-03, Vol.9 (3), p.e001664

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparative safety of BRAF and MEK inhibitors (vemurafenib, dabrafenib and trametinib) in first-line therapy for BRAF-mutated metastatic melanoma

Molecular and clinical oncology, 2016-10, Vol.5 (4), p.458-462

2016

Link zum Volltext

Verfügbarkeit prüfen

Impact of the 21-Gene Assay in Patients with High-Clinical Risk ER-Positive and HER2-Negative Early Breast Cancer: Results of the KARMA Dx Study

Cancers, 2023-02, Vol.15 (5), p.1529

2023

Link zum Volltext

Verfügbarkeit prüfen

Association of TYR SNP rs1042602 with Melanoma Risk and Prognosis

Life (Basel, Switzerland), 2022-12, Vol.12 (12), p.2004

2022

Link zum Volltext

Verfügbarkeit prüfen

Sequence of therapies for advanced BRAFV600E/K melanoma

Annals of translational medicine, 2023-03, Vol.11 (6), p.270-270

2023

Link zum Volltext

Verfügbarkeit prüfen

Impact of vascular endothelial growth factor (VEGF) and hypoxia-inductible factor-1 alpha (HIF-1) expression on the prognosis of locally advanced cervical carcinoma (LACC) treated with radiochemotherapy

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e17023-e17023

2017

Link zum Volltext

Verfügbarkeit prüfen

Access to melanoma drugs in Spain: a cross-sectional survey

Clinical & translational oncology, 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

Access to systemic treatment of non-melanoma skin cancer in Spain: a survey analysis

Clinical & translational oncology, 2024-07

2024

Link zum Volltext

Verfügbarkeit prüfen

Abstract PO-059: COVID-19 in melanoma patients: Spanish register

Clinical cancer research, 2020-09, Vol.26 (18_Supplement), p.PO-059-PO-059

2020

Link zum Volltext

Verfügbarkeit prüfen

Encouraging the Role of Women in the ICT Sector

2019 24th IEEE International Conference on Emerging Technologies and Factory Automation (ETFA), 2019, p.1831-1835

2019

Link zum Volltext
IEEE_Xplore

COVID-19 in melanoma patients: Results of the Spanish Melanoma Group Registry, GRAVID study

Journal of the American Academy of Dermatology, 2021-05, Vol.84 (5), p.1412-1415

2021

Link zum Volltext

Verfügbarkeit prüfen

Early evolution of BRAFV600 status in the blood of melanoma patients correlates with clinical outcome and identifies patients refractory to therapy

Melanoma research, 2018-06, Vol.28 (3), p.195-203

2018

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registry

Clinical & translational oncology, 2023-03, Vol.25 (3), p.768-775

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract 468: BRAF mutation analysis in cell free tumoral DNA (cfDNA) of melanoma patients: results from the prospective study GEM1304 (Spanish Melanoma Group)

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.468-468

2016

Link zum Volltext

Verfügbarkeit prüfen

Dabrafenib plus trametinib for compassionate use in metastatic melanoma: A STROBE-compliant retrospective observational postauthorization study

Medicine (Baltimore), 2017-12, Vol.96 (52), p.e9523

2017

Link zum Volltext

Verfügbarkeit prüfen

Interferon-gamma (INFG), an important marker of response to immune checkpoint blockade (ICB) in non-small cell lung cancer (NSCLC) and melanoma patients

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.11504-11504

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5416: RNA-seq and proteomics to identify response to immunotherapy in advanced melanoma: a Spanish Melanoma Group Study

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.5416-5416

2022

Link zum Volltext

Verfügbarkeit prüfen

A scalp cooling system designed to prevent chemotherapy-induced alopecia: Our experience with implementation at a Spanish public hospital

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e21660-e21660

2016

Link zum Volltext

Verfügbarkeit prüfen

Serum markers and prognosis in locally advanced breast cancer

Tumori, 2005-11, Vol.91 (6), p.522-530

2005

Link zum Volltext

Verfügbarkeit prüfen

Familial melanoma in Spain: Preliminary report of the FAM-GEM-1 study

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e20015-e20015

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(58)

Publikationsform

Artikel
(59)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients

Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial

Liposomal Doxorubicin in the Treatment of Breast Cancer Patients: A Review

Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM)

Comparative safety of BRAF and MEK inhibitors (vemurafenib, dabrafenib and trametinib) in first-line therapy for BRAF-mutated metastatic melanoma

Multi-omics Characterization of Response to PD-1 Inhibitors in Advanced Melanoma

Impact of the 21-Gene Assay in Patients with High-Clinical Risk ER-Positive and HER2-Negative Early Breast Cancer: Results of the KARMA Dx Study

Association of TYR SNP rs1042602 with Melanoma Risk and Prognosis

Sequence of therapies for advanced BRAFV600E/K melanoma

Impact of vascular endothelial growth factor (VEGF) and hypoxia-inductible factor-1 alpha (HIF-1) expression on the prognosis of locally advanced cervical carcinoma (LACC) treated with radiochemotherapy

Access to melanoma drugs in Spain: a cross-sectional survey

Access to systemic treatment of non-melanoma skin cancer in Spain: a survey analysis

Abstract PO-059: COVID-19 in melanoma patients: Spanish register

Encouraging the Role of Women in the ICT Sector

COVID-19 in melanoma patients: Results of the Spanish Melanoma Group Registry, GRAVID study

Early evolution of BRAFV600 status in the blood of melanoma patients correlates with clinical outcome and identifies patients refractory to therapy

SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registry

Abstract 468: BRAF mutation analysis in cell free tumoral DNA (cfDNA) of melanoma patients: results from the prospective study GEM1304 (Spanish Melanoma Group)

Dabrafenib plus trametinib for compassionate use in metastatic melanoma: A STROBE-compliant retrospective observational postauthorization study

Interferon-gamma (INFG), an important marker of response to immune checkpoint blockade (ICB) in non-small cell lung cancer (NSCLC) and melanoma patients

Abstract 5416: RNA-seq and proteomics to identify response to immunotherapy in advanced melanoma: a Spanish Melanoma Group Study

A scalp cooling system designed to prevent chemotherapy-induced alopecia: Our experience with implementation at a Spanish public hospital

Serum markers and prognosis in locally advanced breast cancer

Frequency and characteristics of familial melanoma in Spain: the FAM-GEM-1 Study

Familial melanoma in Spain: Preliminary report of the FAM-GEM-1 study

Suchergebnisse filtern